The Drug for Everything: Over-Diagnosis, Over-Medication, and the Cost of Medicalized Life

When did every feeling become a disease—and every disease a prescription?

Listen to the Episode

In this week’s episode (40) of the A Return to Healing Podcast, Dr. Andy Lazris and Dr. Alan Roth unpack how the medical-industrial complex drives over-medication—turning human emotion and normal aging into profitable diagnoses. From antidepressants to “pre-diseases,” they explore what happens when care becomes commerce.

Get the full story in our latest episode—watch now, and don’t forget to subscribe to our YouTube channel for more insight and honest conversation.

How the Medical-Industrial Complex Fuels Over-Medication

Dr. Lazris notes how psychiatry’s shift toward a “physiologic” model—viewing all mental states as chemical—made drugs the default solution. Pharmaceutical companies funded the studies, shaped the diagnoses, and redefined “normal.”

Dr. Roth describes seeing this firsthand: ten-minute appointments, patients on multiple psychiatric drugs, and the fading art of psychotherapy. “We’re the most medicated country in the world,” he says, “and yet mental illness outcomes are worse than ever.”

Together, they trace a pattern echoed throughout A Return to Healing: as the medical-industrial complex expands, the definition of health shrinks.

Diagnosing Humanity

The doctors draw a direct line from psychiatry to chronic disease: the same narrative inflation that made ADHD, bipolar, and mild dysthymia household terms also rebranded aging, obesity, and diabetes as endless drug markets.

“Being elderly is now a diagnosis,...It’s treatable—with medicines and tests.”

They expose how new billing codes, expanded manuals like the DSM, and the creation of “pre-diseases” (like prediabetes) keep Americans on the hamster wheel of testing, treatment, and dependency.

The irony? Outcomes haven’t improved. “We’re medicating sadness, aging, and being alive,” Dr. Lazris says, “while ignoring the social roots of unhappiness—loneliness, fear, and disconnection.”

Breaking Free from the Medical-Industrial Cycle

In A Return to Healing, the authors argue that this cultural obsession with chemical fixes stems from a loss of primary care and trust. Dr. Roth emphasizes prevention, community, and continuity—the antidotes to both over-treatment and despair.

“Real health comes from relationships,” he says. “Not from refills.”

The podcast closes on a message that bridges science and spirit: that healing means living with imperfection, accepting variability, and caring for ourselves before reaching for another prescription.

Frequently Asked Questions (FAQ)

1. What is the main concern about psychiatric medications?

Drs. Lazris and Roth argue that psychiatric drugs are overprescribed, often replacing talk therapy, community support, and self-awareness. Drug companies shape research and definitions, creating dependency instead of resilience.

2. How does this connect to A Return to Healing?

The book critiques how industrial medicine rewards intervention over prevention. The same forces driving over-medication—profit incentives and fear-based messaging—are those that disconnected medicine from compassion.

3. Are antidepressants and antipsychotics ever appropriate?

Yes—but for targeted, severe conditions, under close supervision. The doctors stress balance: drugs can help, but they shouldn’t define care.

4. Why do so many people believe they’re sick?

Because the healthcare economy depends on it. From commercials to new disease labels, people are taught that every variation is abnormal. Fear drives demand.

5. What’s the alternative?

A return to relationship-based care—where doctors and patients decide together when treatment helps, when watchful waiting is wiser, and when lifestyle and empathy matter most.

Cover of A Return to Healing, a book advocating for patient-centered care and healthcare reform.
Thank you for signing up to our mailing list!

Free Chapter

Click the button below to download your free sample chapter of A Return to Healing, out in bookstores and online March 25, 2025.